TNDM -
Tandem Diabetes Care, Inc.
Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
14.52 0.25 (1.72%) |
--- |
--- |
--- |
--- |
0.25 (1.72%) |
--- |
--- |
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Earnings & Ratios
- Basic EPS:
- -0.78
- Diluted EPS:
- -0.78
- Basic P/E:
- -18.9359
- Diluted P/E:
- -18.9359
- RSI(14) 1m:
- 46.67
- VWAP:
- 14.76
- RVol:
Events
Period |
Kind |
Movement |
Occurred At |
Related News
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Oct 13, 2025 22:55
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Oct 09, 2025 18:51
Global Insulin Delivery Devices Market is Predicted to Reach ~USD 53 Billion by 2032 | DelveInsight
Oct 07, 2025 17:00
INVESTOR ALERT: Investigation of Slide Insurance Holdings, Inc. (SLDE) Announced by Holzer & Holzer, LLC
Oct 07, 2025 12:00
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Sep 30, 2025 20:45
Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Sep 30, 2025 19:00
Tandem t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin in the United States
Sep 29, 2025 12:30
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
Sep 28, 2025 17:49
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Sep 27, 2025 16:47
TNDM Investors Have Opportunity to Join Tandem Diabetes Care, Inc. Fraud Investigation with the Schall Law Firm
Sep 21, 2025 20:37